Proxy Biomedical Announces Expansion
Irish medical implantable devices manufacturer to double cleanroom facilities as part of expansion that will be completed in the second quarter of 2016.
Proxy Biomedical Ltd., Galway, is adding 3000-ft2 of additional cleanroom space rated to Class 8/ 100,000 to support production of new products, according to a company spokesperson, a move that effectively doubles its cleanroom manufacturing space. Proxy declined to reveal the total amount of investment.
Among the products launched in 2015 which are prompting the expansion are resorbable and non-resorbable biomaterials for vascular indication; Proxy Bio-XT, a proprietary process that reinforces resorbable implants for applications including soft tissue fixation in orthopaedics; and ProTEX Med polypropylene, a custom synthesized resin with a FDA Master File reference.
Proxy’s plastics processing capabilities include compression molding, injection molding, lamination and multi-axial laser processing. The company also has what it describes as a number of systems for resorbable polymer material quality control and characterization.
Related Content
-
Use Cavity Pressure Measurement to Simplify GMP-Compliant Medical Molding
Cavity-pressure monitoring describes precisely what’s taking place inside the mold, providing a transparent view of the conditions under which a part is created and ensuring conformance with GMP and ISO 13485 in medical injection molding.
-
Wisconsin Firms Unite in Battle Against Covid
Teel Plastics opened new plant in record time, partnering with AEC & Aqua Poly Equipment Co. to expand production of swab sticks to fight pandemic.
-
Catheter Specialist Finds Sweet Spot Serving Small, Medium-Sized Concerns
Medical-component specialist LightningCath has carved a niche meeting the needs of small to medium-sized entrepreneurs with complex catheter designs … quickly.
